Impact of pathological complete response following neoadjuvant chemotherapy (gemcitabine, nab-paclitaxel, S-1) and radiation for borderline resectable pancreatic cancer: a case report and review of literature

BACKGROUND: Pancreatic cancer (PC) is a highly lethal malignancy, even if surgical resection is possible (median survival: < 30 months). The prognosis of borderline resectable pancreatic cancer (BR-PC) is even worse. There is no clear consensus on the optimal treatment strategy, including pre/pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinoshita, Mitsuru, Watanabe, Sota, Mizojiri, Gaku, Sada, Akitada, Kai, Hiroki, Masuike, Yasunori, Nagasawa, Yoshinobu, Maruyama, Kentaro, Lee, Kyowon, Ohata, Mai, Ishikawa, Osamu, Oka, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474757/
https://www.ncbi.nlm.nih.gov/pubmed/36103018
http://dx.doi.org/10.1186/s40792-022-01529-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474757/
https://www.ncbi.nlm.nih.gov/pubmed/36103018
http://dx.doi.org/10.1186/s40792-022-01529-z

Ejemplares similares